verapamil hydrochloride
- Product NDC
- 50090-0584
- 11-digit product format
- 500900584
- Labeler code
- 50090
- Product ID
- 50090-0584_345c643b-a853-4818-8559-619c7d5e978e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA090700
- Marketing category
- ANDA
- Marketing start
- 2011-08-05
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V3888OEY5R | VERAPAMIL HYDROCHLORIDE | 152-11-4 | VERAPAMIL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-0584-0 | 50090058400 | 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-0584-0) | 2018-12-26 | 0000-00-00 | No | No | Current |
| 50090-0584-4 | 50090058404 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-0584-4) | 2014-11-28 | 0000-00-00 | No | No | Current |